KDIGO 2026 (draft) — KDIGO 2026 AKI/AKD Guideline — Public Review Draft

This is a public-review draft, not a finalized guideline. Its recommendations may still change and should not be treated as current standard of care until publication.

A draft guideline, released for public review in early 2026 (review period extended to May 11, 2026), proposing the first major update to AKI/AKD guidance since 2012 — an expanded framework spanning AKI and Acute Kidney Disease (AKD), updated definitions incorporating structural biomarkers alongside functional (creatinine/urine-output) criteria, and updated guidance on kidney replacement therapy timing, modality, dosing, and discontinuation. This is a public-review draft, not a finalized guideline — its specific recommendations are not yet an established standard of care and are not reproduced here beyond this general description, since the Work Group may still revise them based on review feedback.